Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Dothix - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Dothix

Approved

STANDARD

Dothix

Medico Remedies Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: ac64a86d6ab9d783
Company: Medico Remedies Limited
Type: Standard

Approval Details

Approval Id: ac64a86d6ab9d783
Drug Approval Philippines Name: Dothix
Product Name: Dothix
Registration Number: DRP-7712
Brand Name: Dothix
Generic Name: Doxycycline (As Hyclate)
Dosage Form: capsule
Dosage Strength: 100 mg
Manufacturer: Medico Remedies Limited
Importer: I.E. Medica, Inc.
Distributor: I.E. Medica, Inc.
Issuance Date: 24 November 2020
Expiry Date: 05 March 2026
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

ac64a86d6ab9d783

Type

Standard

Back to Philippines FDA Approvals